At argenx, our commitment to esg is about measuring our progress as a business based on core components that will sustain us on our path to be an integrated, immunology company. · about argenx argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. At argenx, we’ve created an antibody innovation ecosystem where pioneering scientists and antibody engineers work side-by-side to accelerate the discovery of novel targets, disease … At argenx, we are united in our commitment to improve the lives of patients by translating immunology innovations into transformative medicines. At argenx, we are redefining how a biotech company can advance science and deliver innovative treatments. · on , we transferred the legal ownership of all intellectual property rights of argenx se to argenx bv, effective retroactively as of. · argenx stories see where we started — and where we’re going — as we chart a new course together in immunology. · argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. The path to pioneer innovations and … Were enabling new ways of working with partners, patients and each other. Argenx engineers first-in-class therapies for rare diseases – where underserved patients need breakthroughs and the healthcare community needs options. Our franchise-focused approach …